Voyager Therapeutics Inc.
Organization details
- Legal name
- Voyager Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Lexington
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- VYGR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001640266
- Wikidata ID
- Q106411854
Board of directors
-
Alfred Sandrock · Director · President and CEOSince 2023
-
Catherine J. Mackey · DirectorSince 2023
-
George A. Scangos · DirectorSince 2023
-
Glenn Pierce · DirectorSince 2023
-
Grace Colon · DirectorSince 2023
-
James A. Geraghty · DirectorSince 2023
-
Jude Onyia · DirectorSince 2023
-
Michael J. Higgins · DirectorSince 2023
-
Nancy Vitale · DirectorSince 2023
-
Steven Hyman · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
70.5%
-
92.0%
-
96.3%
Board connections
6 of this board's directors also sit on 9 other boards. 8 are in the same sector.
-
Korsana Biosciences Inc. Same sectorvia Michael J. Higgins and Steven Hyman
- via George A. Scangos
-
CAMP4 Therapeutics Corporation Same sectorvia Michael J. Higgins
-
CareDx Inc. Same sectorvia Grace Colon
-
Fulcrum Therapeutics Inc. Same sectorvia James A. Geraghty
-
IDEAYA Biosciences Inc. Same sectorvia Catherine J. Mackey
-
Palvella Therapeutics Inc. Same sectorvia James A. Geraghty
-
Pulmatrix Inc. Same sectorvia Michael J. Higgins
-
Vir Biotechnology Inc. Same sectorvia George A. Scangos
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $297,957
- 11 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 1, 2026 | Carter Todd Alfred Officer (Chief Scientific Officer) | Grant or award | +33,000 | — | — |
| Nov 1, 2026 | Swartz Robin Officer (President) | Grant or award | +68,250 | — | — |
| Apr 2, 2026 | Alfred Sandrock Director, Officer (President and CEO) | Open-market sale | −11,511 | $3.87 | $44,548 |
| Apr 1, 2026 | Shiferman Gregory L. Officer (SVP and General Counsel) | Grant or award | +50,000 | — | — |
| Feb 24, 2026 | Swartz Robin Officer (COO & CBO) | Open-market sale | −6,458 | $3.77 | $24,347 |
| Feb 24, 2026 | Alfred Sandrock Director, Officer (President and CEO) | Open-market sale | −14,197 | $3.79 | $53,807 |
| Feb 24, 2026 | Jorgensen Nathan D. Officer (Chief Financial Officer) | Open-market sale | −4,668 | $3.77 | $17,598 |
| Feb 24, 2026 | Carter Todd Alfred Officer (Chief Scientific Officer) | Open-market sale | −4,174 | $3.76 | $15,694 |
| Feb 18, 2026 | Swartz Robin Officer (COO & CBO) | Open-market sale | −3,882 | $3.44 | $13,354 |
| Feb 18, 2026 | Carter Todd Alfred Officer (Chief Scientific Officer) | Open-market sale | −3,301 | $3.44 | $11,355 |
| Feb 18, 2026 | Alfred Sandrock Director, Officer (President and CEO) | Open-market sale | −11,732 | $3.41 | $40,006 |
| Feb 10, 2026 | Swartz Robin Officer (COO & CBO) | Open-market sale | −4,569 | $3.85 | $17,591 |
| Feb 10, 2026 | Alfred Sandrock Director, Officer (President and CEO) | Open-market sale | −12,192 | $3.78 | $46,086 |
| Feb 10, 2026 | Carter Todd Alfred Officer (Chief Scientific Officer) | Open-market sale | −3,525 | $3.85 | $13,571 |
| Feb 6, 2026 | Ferguson Toby Officer (Chief Medical Officer) | Grant or award | +45,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Voyager Therapeutics Inc.
Who is the CEO of Voyager Therapeutics Inc.?
Alfred Sandrock is Voyager Therapeutics Inc.'s President and CEO.
How many directors are on Voyager Therapeutics Inc.'s board?
Voyager Therapeutics Inc.'s board has 10 directors: Alfred Sandrock, Catherine J. Mackey, George A. Scangos, Glenn Pierce, Grace Colon, James A. Geraghty, Jude Onyia, Michael J. Higgins, Nancy Vitale and Steven Hyman.
Are Voyager Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Voyager Therapeutics Inc. insiders made no open-market purchases and sold $297,957 of shares in 11 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="voyager-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.